YTHDC1 is upregulated throughout this process, and hepatocyte‐specific deletion of Ythdc1 results in impaired liver development, leading to liver injury, inflammation, fibrosis, and pathological changes characteristic of NASH and HCC in mice. Here, YTHDC1 is linked to metabolic dysfunction-associated steatohepatitis.